-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on CG Oncology, Raises Price Target to $82

Benzinga·05/14/2026 14:42:21
Listen to the news
Truist Securities analyst Gregory Renza reiterates CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $77 to $82.